<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/5EE55E7A-9A75-4570-A04D-D9F36C3129EC"><gtr:id>5EE55E7A-9A75-4570-A04D-D9F36C3129EC</gtr:id><gtr:name>National Institutes of Health</gtr:name><gtr:address><gtr:line1>31 Center Drive</gtr:line1><gtr:line2>9000 Rockville Pike</gtr:line2><gtr:postCode>20892</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:department>Sch of Biological Sciences</gtr:department><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/5EE55E7A-9A75-4570-A04D-D9F36C3129EC"><gtr:id>5EE55E7A-9A75-4570-A04D-D9F36C3129EC</gtr:id><gtr:name>National Institutes of Health</gtr:name><gtr:address><gtr:line1>31 Center Drive</gtr:line1><gtr:line2>9000 Rockville Pike</gtr:line2><gtr:postCode>20892</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/4FD2374A-BD17-4E10-AC50-297E1AABFD28"><gtr:id>4FD2374A-BD17-4E10-AC50-297E1AABFD28</gtr:id><gtr:firstName>Malcolm</gtr:firstName><gtr:surname>Walkinshaw</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/77754C4E-2FAD-4B3F-906F-1A7E470D075E"><gtr:id>77754C4E-2FAD-4B3F-906F-1A7E470D075E</gtr:id><gtr:firstName>Nicholas</gtr:firstName><gtr:surname>Turner</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/D15B65D4-A3FE-414F-918B-FCCA37464821"><gtr:id>D15B65D4-A3FE-414F-918B-FCCA37464821</gtr:id><gtr:firstName>Linda</gtr:firstName><gtr:surname>Fothergill-Gilmore</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/4AC9058F-6F82-45DC-B2BD-B6B0BAE808F8"><gtr:id>4AC9058F-6F82-45DC-B2BD-B6B0BAE808F8</gtr:id><gtr:firstName>Paul</gtr:firstName><gtr:otherNames>A</gtr:otherNames><gtr:surname>Michels</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0600014"><gtr:id>67B98861-1419-4669-8F71-2FACD23E352A</gtr:id><gtr:title>Trypanocidal drugs targeting PFK and PYK</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0600014</gtr:grantReference><gtr:abstractText>Protozoan parasites are the cause of serious diseases of the developing world where literally millions of people are at risk and tens of thousands die annually. Current treatments are poor and use very toxic drugs. The parasites have a rather unique biochemical pathway for metabolising sugar. We have characterised two proteins involved in this pathway and have used this information to design and synthesise libraries of drug-like molecules that block the pathway. Our initial trials also show that some of these compounds kill the parasite and show specificity against the parasite compared to mammalian cells. These results provide an excellent starting point for developing more potent and specific molecular families that can be tested as potential drugs. Our approach will lead to two complementary drug families that may provide the basis of a combination therapy that would not only be more potent, but also minimise the risk of the development of resistance in the parasite population.</gtr:abstractText><gtr:technicalSummary>The parasitic protozoa Trypanosoma and Leishmania are the causative agents of several disabling diseases including sleeping sickness and Chagas? disease. Enzymes in the glycolytic pathway of these parasites provide a series of validated drug targets. We have recently solved the X-ray structures phosphofructo kinase (PFK) and pyruvate kinase (PYK) which have been shown by RNAi experiments to be absolutely required for parasite viability. The major aim of this project is to further develop two families of nanomolar drug-like inhibitors: one set of compounds will block the active site of parasite PFK and the second family will block the allosteric site of parasite PYK. These two targets are ideally complementary as both families of inhibitors have similar chemical characteristics. Three chemical libraries of furanose-like PFK and PYK inhibitors have been synthesized and a number of specific inhibitors have been discovered with IC50 values between 20 and 100 ?M. Significantly the current lead compounds kill parasites with ED50 values as low as 30?M and show up to 95% specificity for inhibiting parasite PFK over mammalian enzymes. Structure-based studies using our newly determined X-ray structures suggest the design of modified libraries with enhanced binding and specificity. The project will build on these structure-based and combinatorial chemistry results to develop medically relevant inhibitor families that may provide the basis of novel mono or combination therapies.</gtr:technicalSummary><gtr:fund><gtr:end>2010-03-25</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2007-03-26</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>316819</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Institutes of Health (NIH)</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>NIH roadmap</gtr:description><gtr:id>F374AB5F-3230-41B0-9A63-7672D1886F75</gtr:id><gtr:impact>An R03 grant was funds. Full screening will be complete in 2011 and compounds will be available for testing</gtr:impact><gtr:outcomeId>onxdYCvK5Wm-1</gtr:outcomeId><gtr:partnerContribution>Screening of 300000 compounds against target enzyme</gtr:partnerContribution><gtr:piContribution>Phosphoglycerate mutase screening program at NIH Maryland</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Clan Sutherland Magazine</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>A352F125-5C79-4917-B7A3-3A5ABFBE0849</gtr:id><gtr:impact>Article by LAF-G entitled ?In search of a cure for sleeping sickness? in the biannual magazine published by the Clan Sutherland Society of Scotland.

discussion</gtr:impact><gtr:outcomeId>5C66974E5CA</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Press Gang</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>31321428-5388-4589-A3B7-4C4E748C9C70</gtr:id><gtr:impact>LAF-G founding convener and then member of the Press Gang of the School of Biological Sciences (SBS). This Press Gang is a volunteer group of undergraduates, postgraduates, postdoctoral fellows and academics that are active in several areas related to the dissemination of research in SBS to the wider communities. Members of the Gang identify and prepare news items and liaise with the Press Office; launch regular BioPOD podcasts; encourage participation in outreach work in schools, festivals, exhibitions etc, and prepare material for the University Bulletin, Bionews, SBS website.

Members of the Gang identify and prepare news items and liaise with the Press Office; launch regular BioPOD podcasts; encourage participation in outreach work in schools, festivals, exhibitions etc, and prepare material for the University Bulletin, Bionews, SBS website. The SBS Press Gang was the first to be created at the University of Edinburgh, and its success has meant that it has subsequently been copied by other Schools within the University.</gtr:impact><gtr:outcomeId>36F90E1AF1E</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2007</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>College of Humanities and Social Sciences presentation</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>C8065DE0-E888-401B-AC8B-6FC63BDF7FB6</gtr:id><gtr:impact>26 August 2009 Presentation by LAF-G entitled ?Drug discovery for trypanosomiasis and other related diseases? at a joint meeting for members of the Centre for Infectious Diseases and colleagues in the College of Humanities and Social Sciences.

Interested discussion</gtr:impact><gtr:outcomeId>A5A108DEA93</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>30000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>NIH roadmap</gtr:description><gtr:end>2013-06-02</gtr:end><gtr:fundingOrg>National Institutes of Health (NIH)</gtr:fundingOrg><gtr:id>AB083A02-D20F-4142-970F-4588C5B21039</gtr:id><gtr:outcomeId>CRmgD434Mwf0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2011-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>25000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>NIH Molecular Libraries Roadmap Initiative</gtr:description><gtr:end>2011-06-02</gtr:end><gtr:fundingOrg>National Institutes of Health (NIH)</gtr:fundingOrg><gtr:id>DCC36041-BBCC-4C8A-AECE-A4222ED07A96</gtr:id><gtr:outcomeId>BB7D91D7F210</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2009-06-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Database searching tools for the discovery of small molecule ligands</gtr:description><gtr:id>1547C202-EC9F-4069-BB0F-C38BB5D021C2</gtr:id><gtr:impact>The preexisting database Eduliss contains 5M commercially available compounds. FOr this project a set of pharmacophore searching tools were develeped and used successfully. They are now freely available on the web. http://eduliss.bch.ed.ac.uk/eduliss/</gtr:impact><gtr:outcomeId>7F3088693A5</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>EDULISS</gtr:title><gtr:type>Database/Collection of Data/Biological Samples</gtr:type><gtr:url>http://eduliss.bch.ed.ac.uk/eduliss/</gtr:url><gtr:yearFirstProvided>2008</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>CDA3F012-5AF4-460B-9D61-D42AA87E5B8C</gtr:id><gtr:title>Allosteric pyruvate kinase-based &amp;quot;logic gate&amp;quot; synergistically senses energy and sugar levels in Mycobacterium tuberculosis.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/092f453b828370f5740d825b73540032"><gtr:id>092f453b828370f5740d825b73540032</gtr:id><gtr:otherNames>Zhong W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>5a97ed3e5622b0.23717993</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2279318C-2525-4BD8-A861-E094F0F29EA2</gtr:id><gtr:title>A new family of covalent inhibitors block nucleotide binding to the active site of pyruvate kinase.</gtr:title><gtr:parentPublicationTitle>The Biochemical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0c0a728694ce56c7a4de665db1124c41"><gtr:id>0c0a728694ce56c7a4de665db1124c41</gtr:id><gtr:otherNames>Morgan HP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0264-6021</gtr:issn><gtr:outcomeId>pm_15039_29_22906073</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DACB3092-7959-465C-AD5D-8435ABBCA928</gtr:id><gtr:title>Allosteric mechanism of pyruvate kinase from Leishmania mexicana uses a rock and lock model.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0c0a728694ce56c7a4de665db1124c41"><gtr:id>0c0a728694ce56c7a4de665db1124c41</gtr:id><gtr:otherNames>Morgan HP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>pm_15039_29_20123988</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3750CBB0-2B74-4940-B612-8E7C4BD1D646</gtr:id><gtr:title>Crystal structures of Leishmania mexicana phosphoglycerate mutase suggest a one-metal mechanism and a new enzyme subclass.</gtr:title><gtr:parentPublicationTitle>Journal of molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bbee9f8ad516b74cded23ad71c79e6c8"><gtr:id>bbee9f8ad516b74cded23ad71c79e6c8</gtr:id><gtr:otherNames>Nowicki MW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-2836</gtr:issn><gtr:outcomeId>3C7433A9376</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6E3364A7-D273-461C-962E-EAF23D5E7888</gtr:id><gtr:title>Design and synthesis of conformationally constrained cyclophilin inhibitors showing a cyclosporin-A phenotype in C. elegans.</gtr:title><gtr:parentPublicationTitle>Chembiochem : a European journal of chemical biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/38df855343e68fc1abe309fe298f95ac"><gtr:id>38df855343e68fc1abe309fe298f95ac</gtr:id><gtr:otherNames>Dunsmore CJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1439-4227</gtr:issn><gtr:outcomeId>pm_15039_29_21337480</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>42A96189-87EE-4402-8E20-C9743EC05804</gtr:id><gtr:title>Design, synthesis and trypanocidal activity of lead compounds based on inhibitors of parasite glycolysis.</gtr:title><gtr:parentPublicationTitle>Bioorganic &amp; medicinal chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bbee9f8ad516b74cded23ad71c79e6c8"><gtr:id>bbee9f8ad516b74cded23ad71c79e6c8</gtr:id><gtr:otherNames>Nowicki MW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0968-0896</gtr:issn><gtr:outcomeId>9AB7BE5B90B</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>338CB2C8-80D0-4635-A2D4-1A0A8417C607</gtr:id><gtr:title>The first crystal structure of phosphofructokinase from a eukaryote: Trypanosoma brucei.</gtr:title><gtr:parentPublicationTitle>Journal of molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/095ffdd05ea9ddedbcac3b5b6064bc32"><gtr:id>095ffdd05ea9ddedbcac3b5b6064bc32</gtr:id><gtr:otherNames>Martinez-Oyanedel J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0022-2836</gtr:issn><gtr:outcomeId>0656631F4DA</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>80A30526-E64B-41B2-83AF-CC97E92D4615</gtr:id><gtr:title>The mitosis and neurodevelopment proteins NDE1 and NDEL1 form dimers, tetramers, and polymers with a folded back structure in solution.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0a357e0ee238361d6e9552e06fa76854"><gtr:id>0a357e0ee238361d6e9552e06fa76854</gtr:id><gtr:otherNames>Soares DC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>pm_15039_29_22843697</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BD2B3842-22A4-476C-A49A-533678678671</gtr:id><gtr:title>Structures of Leishmania Fructose-1,6-Bisphosphatase Reveal Species-Specific Differences in the Mechanism of Allosteric Inhibition.</gtr:title><gtr:parentPublicationTitle>Journal of molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2c714cafffc3fd8661677a64000560c4"><gtr:id>2c714cafffc3fd8661677a64000560c4</gtr:id><gtr:otherNames>Yuan M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0022-2836</gtr:issn><gtr:outcomeId>5a97ed3e9413a4.34266886</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5AE78E55-678F-44DD-A435-D4A637996E45</gtr:id><gtr:title>Sulphate removal induces a major conformational change in Leishmania mexicana pyruvate kinase in the crystalline state.</gtr:title><gtr:parentPublicationTitle>Journal of molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8282688f3a4310fb3027fe420b2376cf"><gtr:id>8282688f3a4310fb3027fe420b2376cf</gtr:id><gtr:otherNames>Tulloch LB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-2836</gtr:issn><gtr:outcomeId>7CE8501FEA2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6CF7C9E8-1877-42E9-9068-42D53C3FE0B0</gtr:id><gtr:title>Phosphoglycerate mutase from Trypanosoma brucei is hyperactivated by cobalt in vitro, but not in vivo.</gtr:title><gtr:parentPublicationTitle>Metallomics : integrated biometal science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a1c7e06b68ece551f97533ecc10d6537"><gtr:id>a1c7e06b68ece551f97533ecc10d6537</gtr:id><gtr:otherNames>Fuad FA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1756-5901</gtr:issn><gtr:outcomeId>pm_15039_29_21993954</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>86204D8F-A22B-4476-AE1E-D7DA8F5A821C</gtr:id><gtr:title>An improved strategy for the crystallization of Leishmania mexicana pyruvate kinase.</gtr:title><gtr:parentPublicationTitle>Acta crystallographica. Section F, Structural biology and crystallization communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0c0a728694ce56c7a4de665db1124c41"><gtr:id>0c0a728694ce56c7a4de665db1124c41</gtr:id><gtr:otherNames>Morgan HP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1744-3091</gtr:issn><gtr:outcomeId>pm_15039_29_20208146</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E9A5F93F-1D0C-48F6-90F6-DD1F1E647F0D</gtr:id><gtr:title>The trypanocidal drug suramin and other trypan blue mimetics are inhibitors of pyruvate kinases and bind to the adenosine site.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0c0a728694ce56c7a4de665db1124c41"><gtr:id>0c0a728694ce56c7a4de665db1124c41</gtr:id><gtr:otherNames>Morgan HP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>pm_15039_29_21733839</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9540DFB9-04A9-4B54-90E3-D62D3CFBAE74</gtr:id><gtr:title>The crystal structure of ATP-bound phosphofructokinase from Trypanosoma brucei reveals conformational transitions different from those of other phosphofructokinases.</gtr:title><gtr:parentPublicationTitle>Journal of molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/98a7fa39d5f2bc8a098306515b173f3a"><gtr:id>98a7fa39d5f2bc8a098306515b173f3a</gtr:id><gtr:otherNames>McNae IW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-2836</gtr:issn><gtr:outcomeId>AAF0EA6C649</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0600014</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>8F896112-5A04-4A11-A9F0-2B446D9AAC8A</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>5.1  Pharmaceuticals</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>